Phase Ib data indicate ST-617 can reduce severity of OM in patients receiving chemoradiation June 9, 2021
Selpercatinib shows promising safety and efficacy in RET-altered solid tumors in pediatric patients June 8, 2021
New phase I/II study evaluates AGuIX gadolinium-based nanoparticles in pancreatic and lung cancers June 7, 2021
Enrollment begins in phase I study of RO-7300490 as single agent or in combination with atezolizumab June 7, 2021
RSS